How to position Kipu RCM differently by archetype. What to say and why.
Kipu RCM is the same platform regardless of who buys it. But the way you talk about it changes completely depending on who's across the table. A PE-backed COO doesn't care about "streamlined workflows." They care about EBITDA impact and margin expansion before the next board meeting. A nonprofit ED doesn't care about competitive displacement. They care about whether this helps them keep their SAMHSA grant.
This framework maps value language, objection handling, and competitive positioning to each ownership archetype identified in the ICP Validation Summary. The goal: every rep walks into every meeting with language that resonates with how that buyer defines value, not how we define features.
If you're reading this and thinking "I can just use the same pitch for everyone," that's how deals stall in committee.
What to lead with. What to avoid. Why it matters.
Lead With:
"We reduce net days in A/R by an average of 18 days in the first 90 days. That's cash flow your board can see next quarter."
"Our denial management engine catches authorization gaps before they become write-offs. We're talking 12-15% denial rate reduction."
"You're running 4 facilities on 3 different billing processes. We standardize that without disrupting clinical ops."
Avoid:
"Easy to use": they don't care about UX, they care about margin.
"We integrate with everything": too vague. Name the specific systems.
"Long-term partnership": PE thinks in 3-5 year hold periods. Show near-term impact.
Key metric: EBITDA impact per facility per quarter. Speak in dollars, not percentages.
Lead With:
"You're adding sites faster than your billing team can scale. We make rev cycle a solved problem so you can focus on growth."
"Each new location doesn't need its own billing FTE. We centralize the process."
"Your payer mix is 70%+ commercial. That's exactly where our authorization engine delivers the most value."
Avoid:
"Enterprise-grade": sounds expensive and slow to a growth-stage founder.
"Compliance first": they know compliance matters, but don't lead with fear.
"Implementation takes 6-8 weeks": reframe as "live in under 60 days."
Key metric: Revenue per site with/without Kipu RCM. Show the scaling math.
Lead With:
"42 CFR Part 8 documentation isn't optional. Our system builds compliance into the dispensing workflow so your staff doesn't have to think about it."
"Medicaid reimbursement timelines are brutal. We automate follow-up and reduce time-to-payment by 22 days on average."
"SAMHSA survey coming up? Our audit trail gives you documentation confidence your compliance director will appreciate."
Avoid:
"We handle all payer types": they need Medicaid-specific depth.
"One platform for everything": they need to hear dispensing and Part 8 specifics.
Generic ROI claims: OTP margins are thin. Be precise.
Key metric: Clean claim rate on Medicaid submissions. Audit readiness score.
Lead With:
"Your grant reporting requires outcomes data tied to billing. We connect those two worlds so your team isn't doing double entry."
"Every dollar you recover in underbilled services goes back to your mission. We find the money you're already earning but not collecting."
"Your board wants to see financial sustainability metrics. We give you dashboards that tell that story."
Avoid:
"Revenue maximization": nonprofits hear "aggressive billing" and recoil.
"Competitive advantage": mission-driven orgs don't think in competitive terms.
Pressure tactics: grant cycles move on their own timeline. Respect it.
Key metric: Grant compliance accuracy. Recovered underbilled revenue as % of operating budget.
Lead With:
"You built this facility. You shouldn't have to spend your evenings worrying about whether your biller submitted claims correctly."
"We've seen owner-operators recover $180K-$350K in annual revenue they didn't know they were leaving on the table."
"If you're thinking about succession planning or a future sale, clean rev cycle data increases your valuation."
Avoid:
"Scale your operations": many owner-ops don't want to scale. They want control.
"Replace your billing staff": those staff are often family or long-tenured employees.
Jargon-heavy pitches: speak plain. These buyers value directness.
Key metric: Annual revenue recovered. Peace-of-mind compliance score. Valuation readiness.
Lead With:
"Your BH division's billing doesn't fit the acute care model. We give you a specialized rev cycle layer that works alongside your system EMR."
"IT doesn't want another system to manage. We've done this integration with Epic and Cerner environments before."
"Your BH division is probably the lowest-margin department. We change that math without requiring system-level approvals for every workflow change."
Avoid:
"Replace your current system": IT will kill this immediately.
"Quick implementation": hospital procurement doesn't move quick. Don't promise it.
Bypassing IT: they will find out. Loop them in early.
Key metric: BH division margin improvement. IT integration complexity score. Committee approval timeline.
The objections are predictable. The responses should be too.
| Objection | What They're Really Saying | Response Framework | Archetype Most Likely |
|---|---|---|---|
| "We already have a billing company." | Switching cost feels high. Current vendor is "good enough." | "What's your current denial rate? Most facilities we work with thought theirs was 8-10%. It's usually 15-22%. Can we run a free claims audit to see?" | Owner-Operator, Nonprofit |
| "Our IT team won't approve another system." | Integration anxiety. Past bad experiences. | "We integrate via [specific API/HL7 method]. We've done this alongside Epic, Cerner, and legacy systems. Can we do a 30-minute technical review with your IT lead?" | Hospital-Owned |
| "We can't afford this right now." | Budget isn't allocated. ROI isn't clear enough to fight for it. | "Most clients see the platform pay for itself within 90 days through denial recovery alone. What if we structured a pilot around your highest-denial payer?" | Nonprofit, Owner-Operator |
| "We're in the middle of a transition." | Organizational change. New leadership, M&A, EMR migration. | "That's actually the best time to get rev cycle right. New leadership wants quick wins. What's the timeline on the transition?" | PE-Backed, VC-Backed |
| "We need to see references." | Not objection. Buying signal. They're validating. | "Absolutely. I'll connect you with [archetype-matched reference]. They had a similar setup, [X beds, Y payer mix]. Fair to schedule a follow-up after that call?" | All |
| "What about HIPAA / compliance?" | Risk aversion. Legal team involvement incoming. | "We're SOC 2 Type II certified, BAA-ready on day one, and our compliance documentation is pre-built for your legal review. Can we send the security packet today?" | Hospital-Owned, State/County |
| "We tried something like this before and it failed." | Burned trust. High bar for proof. | "Tell me what went wrong. Seriously, because if those same conditions exist, I'd rather tell you now than waste your time. What was the biggest failure point?" | Owner-Operator, Nonprofit |
| "Our clinical staff won't adopt it." | Change management fear. Past adoption failures. | "Clinical adoption is the #1 predictor of RCM success. That's why we don't go live until your clinical team is trained and comfortable. We measure adoption, not just installation." | All (especially multi-site) |
When you're replacing an incumbent. Not trashing them. Outpositioning them.
Their pitch: "We've been doing this for 20 years. We know behavioral health."
The reality: Most legacy billers are still running manual processes. They know BH payer rules but they're not catching denials in real-time, they're catching them 45 days later in a spreadsheet.
Your angle: "Experience matters. But experience plus automation is what actually moves your A/R. Ask them what their real-time denial interception rate is. If they can't answer that question, that's your answer."
Don't trash legacy billers. Reframe the conversation around speed and visibility.
Their pitch: "Enterprise-scale, proven across thousands of providers."
The reality: Built for acute care. BH is an afterthought. Their "behavioral health module" is usually a skinned version of their med-surg workflow. Authorization requirements, ASAM levels, and clinical documentation standards for SUD/MH are fundamentally different.
Your angle: "They're great at med-surg. We're built for behavioral health. Ask them how they handle ASAM level-of-care transitions in their authorization workflow. If they hesitate, you know."
Position on depth, not breadth. BH specialization is the moat.
Their pitch: "We control it. We know our patients. We trust our people."
The reality: In-house teams are often understaffed, under-trained on payer rule changes, and invisible to leadership until something breaks. The billing manager knows everything, and when they leave, so does the institutional knowledge.
Your angle: "Your billing team is great. But are they catching every authorization gap before it becomes a denial? Are they current on the Q3 payer policy changes? We augment your team, not replace them."
Never position as replacement for their people. Always augmentation.
Their pitch: "It's all in one system. No integration headaches."
The reality: Bundled RCM is a convenience feature, not a revenue optimization engine. It handles claim submission but rarely does proactive denial management, real-time eligibility verification, or authorization tracking with the depth that BH payers require.
Your angle: "All-in-one is great until your denial rate hits 18% and the only answer is 'submit a ticket.' We specialize in the part that actually recovers revenue."
Don't fight the all-in-one narrative. Fight on outcomes.
Two completely different motions. Treat them that way.
Entry point: Account manager warm intro or usage data trigger (high claim volume, rising denial patterns)
Trust level: Already established. They know the platform.
Value prop shift: "You're already generating the clinical data. We just need to close the loop on the revenue side. No new system to learn. No new login."
Discovery focus: Current billing process gaps, not EMR evaluation.
Timeline: 30-45 day close is realistic.
Key objection: "Why didn't you offer this sooner?" Answer: "We built it when it was ready. You're getting it now because the integration is seamless."
Platform extension play. Lowest friction, highest velocity.
Entry point: Outbound prospecting, event leads, referral network
Trust level: Zero. You're proving everything from scratch.
Value prop shift: "We've built the only RCM platform designed specifically for behavioral health billing complexity. We integrate with your current EMR, no rip-and-replace required."
Discovery focus: Full workflow assessment. EMR, billing, clinical documentation, payer mix.
Timeline: 60-120 days depending on archetype and decision-maker access.
Key objection: "We'd need to switch EMRs too?" Answer: "No. We work alongside your current system. The RCM layer is independent."
Full sales cycle. Requires deeper discovery and proof points.
These apply regardless of archetype.
Nobody cares about your denial management engine until they feel the pain of a 19% denial rate. Start with their problem. The feature is the resolution, not the opening.
PE speaks EBITDA. Nonprofits speak grant compliance. Owner-ops speak cash in the bank. Hospitals speak margin contribution. Use their words, not yours.
"We improve outcomes" is meaningless. "We reduce net days in A/R from 52 to 34 in the first quarter" is a conversation starter. Be specific or be ignored.
Don't pretend switching is painless. It isn't. Acknowledge the cost, then show why the cost of staying is higher. Honesty builds more trust than a smooth pitch.
PE-backed: create urgency around board timelines. Nonprofit: align with grant cycles. Owner-op: don't manufacture urgency. Hospital: map to fiscal year budgets. The clock is different for everyone.
After you propose next steps, stop talking. The silence is uncomfortable for you, not for them. Let them process. The best closers know when to stop selling.